Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

Clinical trial NCT02267603 · COMPLETED

Trial details

NCT number: NCT02267603
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Merkel Cell Carcinoma Stage III Merkel Cell Carcinoma AJCC v7 Stage IIIA Merkel Cell Carcinoma AJCC v7 Stage IIIB Merkel Cell Carcinoma AJCC v7 Stage IV Merkel Cell Carcinoma AJCC v7

Start date: 2014-11-25
Primary completion: 2018-02-06
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.